OM Outset Medical, Inc.

4.210USD+1.69%Mkt Cap: 79.14M $P/E: —

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integr…

Key Statistics

Company
Market Cap79.14M USD
Enterprise Value35.08M USD
Revenue (TTM)117.80M USD
Gross Profit46.75M USD
Net Income (TTM)-81.65M USD
Revenue/Share6.46 USD
Last Price4.210 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees310
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.81
PEG—
EV/EBITDA-0.56
EV/Revenue0.30
P/S0.66
P/B0.81
EPS (TTM)-4.02
EPS (Forward)-2.29
52W Range
2.84110% of range16.16
52W High16.16 USD
52W Low2.841 USD
Profitability
Gross Margin39.13%
Oper. Margin-49.55%
EBITDA Margin-53.25%
Profit Margin-68.34%
ROE-64.32%
ROA-30.87%
Growth
Revenue Growth0.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-46.33M USD
CapEx (TTM)798.00K USD
FCF Margin-12.46%
FCF Yield-18.55%
Net Debt-42.74M USD
Net Debt/EBITDA0.68
Balance Sheet
Debt/Equity0.80
Current Ratio5.19
Quick Ratio4.02
Book Value/Sh5.13 USD
Cash/Share7.83 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateMar 20, 2025
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.667 USD
Upside (mean)+82.1%
Target Range6.000 USD – 10.00 USD
6.000+82.1% to mean10.00
# Analysts3
Ownership
Shares Out.18.80M
Float14.77M
Insiders5.46%
Institutions73.90%
Short Interest
Short Ratio6.5d
Short % Float6.40%
Short % Out.4.73%
Shares Short889.58K
Short (prev mo.)936.34K
Technical
SMA 503.948 (+6.6%)
SMA 2004.148 (+1.5%)
Beta1.99
S&P 52W Chg16.45%
Avg Vol (30d)192.64K
Avg Vol (10d)270.20K
Technical Indicators
RSI (14)64.3
MACD0.0007
MACD Signal-0.1726
MACD Hist.+0.1733
BB Upper4.223 USD
BB Middle3.400 USD
BB Lower2.577 USD
BB Width48.42%
ATR (14)0.2886 USD
Vol Ratio (20d)0.63x